Patient groups are non-profit organizations that focus on the needs of people affected by a specific disease. Over the years, patient groups have assumed an increasingly decisive role in the healthcare decision-making process, and may influence the governments' decisions on key crucial health matters. Financial support for patient groups can come from different sources, including the pharmaceutical and medical device industries. Although patient groups may certainly benefit from drug companies economic support, in this commentary we address concerns regarding the presence of potential conflict of interests (COIs), which may affect the independence, objectivity, integrity and reputation of the organizations. Una prospettiva critica sui gruppi di pazienti e sui finanziamenti dell'industria.
ASJC Scopus subject areas